Skip to main content
NIH funding notice PAR-20-159

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

Closed on May 7, 2023.

Posted
March 31, 2020
Close date
May 7, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,398,541 in first-year total cost, median $236,100.

Most frequent study sections

  1. Emerging Imaging Technologies in Neuroscience Study Section[EITN]1
  2. Pathophysiological Basis of Mental Disorders and Addictions Study Section[PMDA]1
  3. Special Emphasis Panel[ZRG1 AN-C (02)]1
  4. Special Emphasis Panel[ZRG1 BBBP-J (90)]1
  5. Special Emphasis Panel[ZRG1 MDCN-P (56)]1

Most frequent institutions

  1. FLORIDA ATLANTIC UNIVERSITY1
  2. LEHIGH UNIVERSITY1
  3. MASSACHUSETTS GENERAL HOSPITAL1
  4. STANFORD UNIVERSITY1
  5. WAKE FOREST UNIVERSITY HEALTH SCIENCES1
Competing awards under PAR-20-159 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Assess Neural Circuits and Subtypes Underlying Dimensions of Neuropsychiatric Symptoms in Alzheimer's Disease1R21AG080425-01A1ZHANG, YULEHIGH UNIVERSITY, PA$199,476ZRG1
2022Serotonergic IL-1R1 and Neuropsychiatric Traits of an Alzheimer's Mouse Model1R21AG074846-01A1ASHERY, URIBLAKELY, RANDY D.FLORIDA ATLANTIC UNIVERSITY, FL$379,177ZRG1
2022Estrogen depletion as a risk factor for Neuropsychiatric Symptoms associated with aging1R21AG077271-01GOULD, ROBERT WARRENWAKE FOREST UNIVERSITY HEALTH SCIENCES, NC$373,788PMDA
2022Circuit-specific neuromodulation for the treatment of apathy in Alzheimer's Disease1R21AG078985-01ELDAIEF, MARK CHRISTIANNUMMENMAA, AAPOMASSACHUSETTS GENERAL HOSPITAL, MA$210,000ZRG1
2021Identification of Brain Circuit Markers for Psychosis in Alzheimer's Disease by Leveraging Big Data and Machine Learning1R21AG072114-01SUPEKAR, KAUSTUBH SATYENDRASTANFORD UNIVERSITY, CA$236,100EITN

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-20-159: Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) | ScienceDex | ConductScience